Roche reports further accelerated sales growth in third quarter

Group sales up 3.1 billion to 36.4 billion Swiss francs in first nine months, an increase of 11% in local currencies (9% in Swiss francs); both divisions grow significantly faster than their respective markets ; Genentech integration progressing successfully; New Group leadership appointed